-
Recent posts
- Pricing Transparency debate at World Health Assembly May 2019 May 21, 2019
- Bedaquiline donations threaten sustainable, affordable access for patients; letter to India’s Health Minister May 10, 2019
- World Health Day April 7 2019 April 2, 2019
- Ken Harvey is the new president of Friends of Science in Medicine (FSM). February 11, 2019
- Quality control of Australia’s complementary medicines industry January 30, 2019
Archives
- May 2019
- April 2019
- February 2019
- January 2019
- December 2018
- November 2018
- April 2018
- March 2018
- December 2017
- November 2017
- October 2017
- September 2017
- June 2017
- May 2017
- December 2016
- November 2016
- October 2016
- August 2016
- June 2016
- February 2016
- January 2016
- December 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
Author Archives: Mira Shiva
Unbanning 344 Fixed Drug Combinations in India
After the Drug Controller General of India (DCGI) banned the 344 irrational FDCs in March 2016, Pfizer petitioned the Delhi High Court challenging the ban order asking for a stay order against the ban – which was granted unfortunately almost … Continue reading
Posted in Uncategorized
Comments Off on Unbanning 344 Fixed Drug Combinations in India
Drug Information Association Conference in Mumbai
Dr Mira Shiva The Drug Information Association of India Conference is currently being held in Mumbai. The theme is Future of Health Care in India: Patients, Innovation & Access . I am chairing the session on Status of Patient Advocacy … Continue reading
Posted in Uncategorized
Leave a comment